JF

24

May2014

Common Drug Review (CDR) introduces new application fee for submissions

Common Drug Review (CDR) introduces new application fee for submissions The Canadian Agency for Drugs and Technologies in Health (CADTH) is introducing an industry application fee for submissions made by drug manufacturers to CDR effective September 1, 2014 (April 1, 2015 for drugs submitted to the pan-Canadian Oncology Drug Review). All submissions with a ... Read More

23

May2014

The PMPRB releases the April 2014 issue of its NEWSletter

Note worthy news featured in this edition include: Anna Chodos and Beatrice Mullington retire Final requirements for HDAP submissions Online Filing of Form 2 - Project Update CPI-Based Price-Adjustment Factors for 2015 The Hearing Panel approved a VCU in the Teva Canada Innovation G.P-S.E.N.C. and the medicine Copaxone matter New Publication - NPDUIS Research ... Read More

23

May2014

Québec: Update to the Liste de médicaments

The Institut national d’excellence en santé et en services sociaux (INESSS) has released its list of drugs under review for the October 2014 Liste de médicaments. Comments from health professional groups and associations regarding these drugs can be sent to INESSS by May 30th, ... Read More

22

May2014

CADTH: CDEC to review Drugs for Rare Diseases via “enhanced” CDR process

CDEC will review and provide recommendations on reimbursement of drugs for rare diseases (DRDs) according to an enhanced Common Drug Review approach, as per news released today in CDR Update- Issue 103. CADTH incorporated suggestions from stakeholder feedback (invited in October ... Read More

18

Feb2014

Actual CPI in 2013 and implications for PMPRB price compliance

Statistic Canada has released the final Consumer Price Index (CPI) figure for 2013 with full year annual inflation as measured by CPI increasing by 0.9% over 2012. For PMPRB price compliance, this is important for two reasons. First, this is the second year running ... Read More

18

Feb2014

Second phase of generic pricing policy implemented yesterday

Yesterday marked the beginning of the second phase of the provincial government’s generic drug pricing policy in Newfoundland and Labrador. Generic drugs will now be priced at no more than 40% of the brand price.  The province has also now finalized an agreement with the Pharmacists’ Association of Newfoundland and ... Read More

18

Feb2014

Premier Announces New Catastrophic Drug Coverage Program

Prince Edward Island Premier Robert Ghiz announced a new drug coverage program in a press release today. Designed to “protect individuals and families whose drug costs are consuming an unreasonable share of their income”, the Catastrophic Drug Plan formulary will include approximately 60 drugs and be managed by an expert ... Read More

18

Feb2014

Generic drug prices drop to 35 per cent of brand

The final phase of Nova Scotia’s Fair Drug Pricing, bringing the price the province pays for generic drugs down to 35 per cent of the relevant brand price, goes into effect in the province today. This is the last of the three-step phase-in of the policy that began in July ... Read More

18

Feb2014

Provincial government invests $2.4 million in health research

Premier David Alward makes announcement during a dialogue session with Canada's research-based pharmaceutical companies.  Read more

18

Feb2014

INESSS to have meetings with manufacturers for June 2014 Liste des médicaments update

The Institut national d’excellence en santé et en services sociaux will have meetings with manufacturers who have submitted applications in advance of the deadline for the June 2014 Liste des médicaments update. Discussions will address clinical studies and economic and pharmacoeconomic aspects of the submissions. Meetings will be held between December 16, 2013 and ... Read More